Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EMD Serono
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, between the ages of 18 and 60 years
Subject is able to learn and self-administer subcutaneous injections (a care-giver may be trained to inject the subject)
Subjects must have a current diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) (according to the 2010 McDonald MS diagnostic criteria)
You may not be if
Any multiple sclerosis categorized as primary progressive, secondary progressive or progressive relapsing
Allergy to mannitol, plovamer acetate, Copaxone (glatiramer acetate), Gd contrast for MRI
Any requirement for continuous systemic glucocorticoid administration during the trial period. (Note: Treatment with interferons such as Avonex®, Rebif®, or Betaseron® will be allowed until the baseline visit, as no wash-out period is needed)
